Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations - Schedule of Discontinued Operation of Balance Sheet and Operation Statement (Details)

v3.10.0.1
Discontinued Operations - Schedule of Discontinued Operation of Balance Sheet and Operation Statement (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Cash $ 11,689   $ 11,689   $ 17,554
Accounts receivable, net 220,909   220,909   179,737
Prepaid expenses and other current assets 36,928   36,928   29,441
Current assets classified as held for sale 269,526   269,526   226,732
Property and equipment, net 11,449   11,449   21,078
Deposits 6,029   6,029   7,756
Non-current assets classified as held for sale 17,478   17,478   28,834
Accounts payable (includes related parties) 938,989   938,989   1,078,965
Accrued expenses 767,222   767,222   644,300
Current portion of notes payable 325,603   325,603   249,589
Current liabilities classified as held for sale 2,031,814   2,031,814   1,972,854
Revenue from services 506,038 $ 486,614 870,812 $ 997,886  
Cost of services 28,677 37,740 88,097 76,150  
Gross profit 477,361 448,874 782,715 921,736  
Operating expenses 1,144,057 605,272 1,315,040 2,657,701  
Other (income) expenses 11,225 (9,821) (807,541) 8,244  
Income/(Loss) from discontinued operations (677,921) (146,577) 275,216 (1,744,209)  
Advanced Molecular Services Group [Member]          
Cash 5,121   5,121   9,273
Accounts receivable, net 5,947   5,947   19,022
Prepaid expenses and other current assets 25,477   25,477   25,477
Current assets classified as held for sale 36,545   36,545   53,772
Accounts payable (includes related parties) 480,013   480,013   671,561
Accrued expenses 396,440   396,440   375,165
Current portion of notes payable 325,603   325,603   249,589
Current liabilities classified as held for sale 1,202,056   1,202,056   1,296,315
Revenue from services 45,156 46,526 78,841 223,104  
Cost of services 6,075 22,214 769  
Gross profit 39,080 46,526 56,627 222,335  
Operating expenses 94,683 370,873 270,885 897,406  
Other (income) expenses (13,313) 11,225 (813,510) 8,244  
Income/(Loss) from discontinued operations (42,290) (335,572) 599,252 (683,315)  
Health Technology Solutions, Inc [Member]          
Cash 6,568   6,568   8,281
Accounts receivable, net 214,962   214,962   160,715
Prepaid expenses and other current assets 11,451   11,451   3,964
Current assets classified as held for sale 232,981   232,981   172,960
Property and equipment, net 11,449   11,449   21,078
Deposits 6,029   6,029   7,756
Non-current assets classified as held for sale 17,478   17,478   28,834
Accounts payable (includes related parties) 458,976   458,976   407,404
Accrued expenses 370,782   370,782   269,135
Current liabilities classified as held for sale 829,758   829,758   $ 676,539
Revenue from services 441,458 459,512 791,971 774,782  
Cost of services 31,665 28,677 65,883 75,381  
Gross profit 409,793 430,835 726,088 699,401  
Operating expenses 510,589 773,184 1,044,155 1,760,295  
Other (income) expenses 3,491 5,969  
Income/(Loss) from discontinued operations $ (104,287) $ (342,349) $ (324,036) $ (1,060,894)